Results 101 to 110 of about 4,987,259 (403)

Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences

Journal of Nuclear Medicine, 2020
The COVID-19 pandemic has now reached most countries and is straining health-care systems worldwide to their limits. Emergency room and intensive care staff are at increased risk for infection.
J. Czernin, S. Fanti, P. Meyer, M. Allen-Auerbach, M. Hacker, M. Sathekge, R. Hicks, A. Scott, J. Hatazawa, M. Yun, H. Schöder, P. Bartenstein, K. Herrmann   +12 more
semanticscholar   +1 more source

Melanoma and Nuclear Medicine [PDF]

Melanoma Management, 2014
Supported by a large body of published work, the contribution of nuclear medicine technologies to the assessment of melanoma has been increasing in recent years. Lymphoscintigraphy-assisted sentinel lymph node biopsy and PET are in continuous evolution with the aid of technological imaging advances, making it possible to fuse functional and anatomic ...
Sergi Vidal-Sicart, Omgo E. Nieweg, Andrés Perissinotti, Renato A. Valdés Olmos, Renato A. Valdés Olmos   +4 more
openaire   +3 more sources

Cyclic nucleotide signaling as a drug target in retinitis pigmentosa

FEBS Letters, EarlyView.
Disruptions in cGMP and cAMP signaling can contribute to retinal dysfunction and photoreceptor loss in retinitis pigmentosa. This perspective examines the mechanisms and evaluates emerging evidence on targeting these pathways as a potential therapeutic strategy to slow or prevent retinal degeneration.
Katri Vainionpää, Ahmed B. Montaser, Henri Leinonen   +2 more
wiley   +1 more source

Response to neoadjuvant chemotherapy in early breast cancers is associated with epithelial–mesenchymal transition and tumor‐infiltrating lymphocytes

Molecular Oncology, EarlyView.
Epithelial–mesenchymal transition (EMT) and tumor‐infiltrating lymphocytes (TILs) are associated with early breast cancer response to neoadjuvant chemotherapy (NAC). This study evaluated EMT and TIL shifts, with immunofluorescence and RNA sequencing, at diagnosis and in residual tumors as potential biomarkers associated with treatment response.
Françoise Derouane, Jérôme Ambroise, Cédric van Marcke, Mieke Van Bockstal, Martine Berlière, Christine Galant, Hélène Dano, Médina Lougué, Elena Benidovskaya, Guy Jerusalem, Vincent Bours, Claire Josse, Jérôme Thiry, Aurélie Daumerie, Caroline Bouzin, Cyril Corbet, François P. Duhoux   +16 more
wiley   +1 more source

Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer

Journal of Nuclear Medicine, 2020
1Society of Nuclear Medicine and Molecular Imaging, Reston, Virginia; 2American Academy of Family Physicians, Washington, DC; 3American College of Nuclear Medicine, Reston, Virginia; 4European Association of Nuclear Medicine, Vienna, Austria; 5American ...
K. Donohoe, Jennifer Aloff, A. Avram, K. Bennet, L. Giovanella, B. Greenspan, Seza Gulec, Aamna Hassan, R. Kloos, C. Solórzano, B. Stack, M. Tulchinsky, R. Tuttle, D. Van Nostrand, J. Wexler   +14 more
semanticscholar   +1 more source

TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis

Molecular Oncology, EarlyView.
TOMM20 increases cancer aggressiveness by maintaining a reduced state with increased NADH and NADPH levels, oxidative phosphorylation (OXPHOS), and apoptosis resistance while reducing reactive oxygen species (ROS) levels. Conversely, CRISPR‐Cas9 knockdown of TOMM20 alters these cancer‐aggressive traits.
Ranakul Islam, Megan E. Roche, Zhao Lin, Diana Whitaker‐Menezes, Victor Diaz‐Barros, Eurico Serrano, Maria Paula Martinez Cantarin, Nancy J. Philp, Atrayee Basu Mallick, Ubaldo Martinez‐Outschoorn   +9 more
wiley   +1 more source

Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project

Journal of Nuclear Medicine, 2020
The Nuclear Medicine Global Initiative was formed in 2012 by 13 international organizations to promote human health by advancing the field of nuclear medicine and molecular imaging by supporting the practice and application of nuclear medicine. The first
C. Cutler, E. Bailey, Vijay Kumar, S. Schwarz, H. Bom, J. Hatazawa, D. Paez, P. Orellana, L. Louw, F. Mut, H. Kato, A. Chiti, S. Frangos, F. Fahey, G. Dillehay, S. Oh, D. Lee, S. Lee, Rodolfo Nuñez-Miller, G. Bandhopadhyaya, P. Pradhan, A. Scott   +21 more
semanticscholar   +1 more source

Plasma lipidomic and metabolomic profiles in high‐grade glioma patients before and after 72‐h presurgery water‐only fasting

Molecular Oncology, EarlyView.
Presurgery 72‐h fasting in GB patients leads to adaptations of plasma lipids and polar metabolites. Fasting reduces lysophosphatidylcholines and increases free fatty acids, shifts triglycerides toward long‐chain TGs and increases branched‐chain amino acids, alpha aminobutyric acid, and uric acid.
Iris Divé, Lisa Hahnefeld, Katharina J. Wenger, Donat Kögel, Joachim Steinbach, Gerd Geisslinger, Michael W. Ronellenfitsch, Irmgard Tegeder   +7 more
wiley   +1 more source

Radiographic features of liver allograft rejection [PDF]

, 1986
The radiographic features of 19 transplanted patients with failure of the liver allograft were evaluated. These features were: poor filling, stretching, attenuation of intrahepatic biliary ducts documented by T-tube cholangiogram, attenuation of branches
AB Zajko, David H. Thiel, DH Thiel Van, James W. Lecky, RH Fennel, Rodrigo Dominguez, TE Starzl, TE Starzl, Thomas E. Starzl, Valentin Cuervas-Mons   +9 more
core   +1 more source

OpenDose: Open-Access Resource for Nuclear Medicine Dosimetry

Journal of Nuclear Medicine, 2020
Radiopharmaceutical dosimetry depends on the localization in space and time of radioactive sources and requires the estimation of the amount of energy emitted by the sources deposited within targets.
M. Chauvin, D. Borys, F. Botta, Pawel Bzowski, J. Dabin, A. Denis-Bacelar, A. Desbrée, N. Falzone, B. Q. Lee, Andrea Mairiani, A. Malaroda, Gilles Mathieu, E. McKay, E. Mora-Ramirez, A. Robinson, David Sarrut, L. Struelens, A. Vergara Gil, M. Bardiès   +18 more
semanticscholar   +1 more source